From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...

Descripción completa

Detalles Bibliográficos

Autores principales:	Leonor Vasconcelos de Matos, Leonor Fernandes, Maria Teresa Neves, Fátima Alves, Mafalda Baleiras, André Ferreira, Pedro Giesteira Cotovio, Tiago Dias Domingues, Mariana Malheiro, Ana Plácido, Maria Helena Miranda, Ana Martins
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2021-02-01
Colección:	Current Oncology
Materias:	breast cancer aromatase inhibitors osteoporosis fracture
Acceso en línea:	https://www.mdpi.com/1718-7729/28/2/104
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!